{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T14:23:49Z","timestamp":1792592629027,"version":"4.5.0"},"reference-count":113,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004191","name":"Novo Nordisk","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004191","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jthjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Thrombosis and Haemostasis"],"published-print":{"date-parts":[[2022,6]]},"DOI":"10.1111\/jth.15697","type":"journal-article","created":{"date-parts":[[2022,3,13]],"date-time":"2022-03-13T04:16:05Z","timestamp":1647144965000},"page":"1290-1300","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":75,"title":["Regulation of coagulation by tissue factor pathway inhibitor: Implications for hemophilia therapy"],"prefix":"10.1016","volume":"20","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3740-0318","authenticated-orcid":false,"given":"Alan E.","family":"Mast","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6064-2166","authenticated-orcid":false,"given":"Wolfram","family":"Ruf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1111\/jth.15697_bb0010","doi-asserted-by":"crossref","first-page":"18832","DOI":"10.1016\/S0021-9258(18)51542-8","article-title":"Purification and characterization of the lipoprotein\u2010associated coagulation inhibitor from human plasma","volume":"264","author":"Novotny","year":"1989","journal-title":"J Biol Chem"},{"key":"10.1111\/jth.15697_bb0015","doi-asserted-by":"crossref","first-page":"2020","DOI":"10.1182\/blood.V72.6.2020.2020","article-title":"Platelets secrete a coagulation inhibitor functionally and antigenically similar to the lipoprotein associated coagulation inhibitor","volume":"72","author":"Novotny","year":"1988","journal-title":"Blood"},{"key":"10.1111\/jth.15697_bb0020","doi-asserted-by":"crossref","first-page":"1931","DOI":"10.1182\/blood-2006-07-037283","article-title":"Active tissue factor pathway inhibitor is expressed on the surface of coated platelets","volume":"109","author":"Maroney","year":"2007","journal-title":"Blood"},{"key":"10.1111\/jth.15697_bb0025","doi-asserted-by":"crossref","first-page":"1942","DOI":"10.1161\/ATVBAHA.120.315728","article-title":"Major reservoir for heparin\u2010releasable TFPIalpha (tissue factor pathway inhibitor alpha) is extracellular matrix","volume":"41","author":"Peterson","year":"2021","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1111\/jth.15697_bb0030","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1111\/j.1538-7836.2009.03454.x","article-title":"Temporal expression of alternatively spliced forms of tissue factor pathway inhibitor in mice","volume":"7","author":"Maroney","year":"2009","journal-title":"J Thromb Haemost"},{"key":"10.1111\/jth.15697_bb0035","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.1182\/blood-2009-10-250910","article-title":"Endothelial\u2010derived tissue factor pathway inhibitor regulates arterial thrombosis but is not required for development or hemostasis","volume":"116","author":"White","year":"2010","journal-title":"Blood"},{"key":"10.1111\/jth.15697_bb0040","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1182\/blood.2019001530","article-title":"Tissue factor pathway inhibitor primes monocytes for antiphospholipid antibody\u2010induced thrombosis","volume":"134","author":"Muller\u2010Calleja","year":"2019","journal-title":"Blood"},{"key":"10.1111\/jth.15697_bb0045","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1161\/ATVBAHA.115.305996","article-title":"Tissue factor pathway inhibitor: multiple anticoagulant activities for a single protein","volume":"36","author":"Mast","year":"2016","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1111\/jth.15697_bb0050","doi-asserted-by":"crossref","first-page":"2934","DOI":"10.1182\/blood-2013-11-512764","article-title":"Biology of tissue factor pathway inhibitor","volume":"123","author":"Wood","year":"2014","journal-title":"Blood"},{"key":"10.1111\/jth.15697_bb0055","doi-asserted-by":"crossref","first-page":"17838","DOI":"10.1073\/pnas.1310444110","article-title":"Tissue factor pathway inhibitor\u2010alpha inhibits prothrombinase during the initiation of blood coagulation","volume":"110","author":"Wood","year":"2013","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1111\/jth.15697_bb0060","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1182\/blood.V69.2.645.645","article-title":"Studies of a mechanism inhibiting the initiation of the extrinsic pathway of coagulation","volume":"69","author":"Rao","year":"1987","journal-title":"Blood"},{"key":"10.1111\/jth.15697_bb0065","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1097\/00001721-199507000-00004","article-title":"Blocking of tissue factor pathway inhibitor (TFPI) shortens the bleeding time in rabbits with antibody induced haemophilia A","volume":"6","author":"Erhardtsen","year":"1995","journal-title":"Blood Coagul Fibrinolysis"},{"key":"10.1111\/jth.15697_bb0070","doi-asserted-by":"crossref","first-page":"7623","DOI":"10.1073\/pnas.87.19.7623","article-title":"Hemophilia as a defect of the tissue factor pathway of blood coagulation: effect of factors VIII and IX on factor X activation in a continuous\u2010flow reactor","volume":"87","author":"Repke","year":"1990","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1111\/jth.15697_bb0075","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1055\/s-0038-1646439","article-title":"Inhibition of extrinsic pathway inhibitor shortens the coagulation time of normal plasma and of hemophilia plasma","volume":"66","author":"Nordfang","year":"1991","journal-title":"Thromb Haemost"},{"key":"10.1111\/jth.15697_bb0080","doi-asserted-by":"crossref","first-page":"5871","DOI":"10.1182\/blood-2012-01-401620","article-title":"Hemostatic effect of a monoclonal antibody mAb 2021 blocking the interaction between FXa and TFPI in a rabbit hemophilia model","volume":"119","author":"Hilden","year":"2012","journal-title":"Blood"},{"key":"10.1111\/jth.15697_bb0085","doi-asserted-by":"crossref","first-page":"1722","DOI":"10.1111\/jth.14207","article-title":"A first\u2010in\u2010human study of the safety, tolerability, pharmacokinetics and pharmacodynamics of PF\u201006741086, an anti\u2010tissue factor pathway inhibitor mAb, in healthy volunteers","volume":"16","author":"Cardinal","year":"2018","journal-title":"J Thromb Haemost"},{"key":"10.1111\/jth.15697_bb0090","doi-asserted-by":"crossref","first-page":"1973","DOI":"10.1182\/blood.2019001542","article-title":"Subcutaneous concizumab prophylaxis in hemophilia A and hemophilia A\/B with inhibitors: phase 2 trial results","volume":"134","author":"Shapiro","year":"2019","journal-title":"Blood"},{"key":"10.1111\/jth.15697_bb0095","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1111\/jth.12864","article-title":"Safety and pharmacokinetics of anti\u2010TFPI antibody (concizumab) in healthy volunteers and patients with hemophilia: a randomized first human dose trial","volume":"13","author":"Chowdary","year":"2015","journal-title":"J Thromb Haemost"},{"key":"10.1111\/jth.15697_bb0100","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1111\/jth.12188","article-title":"Comparison of the inhibitory activities of human tissue factor pathway inhibitor (TFPI)alpha and TFPIbeta","volume":"11","author":"Maroney","year":"2013","journal-title":"J Thromb Haemost"},{"key":"10.1111\/jth.15697_bb0105","doi-asserted-by":"crossref","first-page":"2384","DOI":"10.1182\/blood-2004-09-3422","article-title":"Regulation of tissue factor\u2010induced signaling by endogenous and recombinant tissue factor pathway inhibitor 1","volume":"105","author":"Ahamed","year":"2005","journal-title":"Blood"},{"issue":"Suppl 1","key":"10.1111\/jth.15697_bb0110","doi-asserted-by":"crossref","first-page":"S52","DOI":"10.1016\/j.thromres.2010.01.038","article-title":"Alternatively spliced isoforms of tissue factor pathway inhibitor","volume":"125","author":"Maroney","year":"2010","journal-title":"Thromb Res"},{"key":"10.1111\/jth.15697_bb0115","doi-asserted-by":"crossref","first-page":"5059","DOI":"10.1182\/blood-2012-05-432005","article-title":"Identification of functionally important residues in TFPI Kunitz domain 3 required for the enhancement of its activity by protein S","volume":"120","author":"Ahnstrom","year":"2012","journal-title":"Blood"},{"key":"10.1111\/jth.15697_bb0120","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1097\/00001721-199304050-00001","article-title":"Structural requirements for tissue factor pathway inhibitor interactions with factor Xa and heparin","volume":"4","author":"Wesselschmidt","year":"1993","journal-title":"Blood Coagul Fibrinolysis"},{"key":"10.1111\/jth.15697_bb0125","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1111\/bjh.14182","article-title":"Blocking inhibition of prothrombinase by tissue factor pathway inhibitor alpha: a procoagulant property of heparins","volume":"175","author":"Wood","year":"2016","journal-title":"Br J Haematol"},{"key":"10.1111\/jth.15697_bb0130","doi-asserted-by":"crossref","first-page":"2677","DOI":"10.1111\/j.1538-7836.2005.01636.x","article-title":"Comparison of cell\u2010surface TFPIalpha and beta","volume":"3","author":"Piro","year":"2005","journal-title":"J Thromb Haemost"},{"key":"10.1111\/jth.15697_bb0135","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1002\/rth2.12058","article-title":"Correlates of plasma and platelet tissue factor pathway inhibitor, factor V, and protein S","volume":"2","author":"Ellery","year":"2018","journal-title":"Res Pract Thromb Haemost"},{"key":"10.1111\/jth.15697_bb0140","doi-asserted-by":"crossref","first-page":"3615","DOI":"10.1182\/blood-2008-06-162453","article-title":"Low plasma levels of tissue factor pathway inhibitor in patients with congenital factor V deficiency","volume":"112","author":"Duckers","year":"2008","journal-title":"Blood"},{"key":"10.1111\/jth.15697_bb0145","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1111\/j.1538-7836.2009.03712.x","article-title":"Hereditary and acquired protein S deficiencies are associated with low TFPI levels in plasma","volume":"8","author":"Castoldi","year":"2010","journal-title":"J Thromb Haemost"},{"key":"10.1111\/jth.15697_bb0150","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1016\/0049-3848(88)90340-4","article-title":"Heparin induces release of extrinsic coagulation pathway inhibitor (EPI)","volume":"50","author":"Sandset","year":"1988","journal-title":"Thromb Res"},{"key":"10.1111\/jth.15697_bb0155","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1042\/bj3270577","article-title":"Glypican\u20103 is a binding protein on the HepG2 cell surface for tissue factor pathway inhibitor","volume":"327","author":"Mast","year":"1997","journal-title":"Biochem J"},{"key":"10.1111\/jth.15697_bb0160","doi-asserted-by":"crossref","first-page":"5914","DOI":"10.1074\/jbc.271.10.5914","article-title":"Human ryudocan from endothelium\u2010like cells binds basic fibroblast growth factor, midkine, and tissue factor pathway inhibitor","volume":"271","author":"Kojima","year":"1996","journal-title":"J Biol Chem"},{"key":"10.1111\/jth.15697_bb0165","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0117404","article-title":"Syndecan\u20103 and TFPI colocalize on the surface of endothelial\u2010, smooth muscle\u2010, and cancer cells","volume":"10","author":"Tinholt","year":"2015","journal-title":"PLoS One"},{"key":"10.1111\/jth.15697_bb0170","doi-asserted-by":"crossref","first-page":"3567","DOI":"10.1161\/01.CIR.0000148778.76917.89","article-title":"Role for the Kunitz\u20103 domain of tissue factor pathway inhibitor\u2010alpha in cell surface binding","volume":"110","author":"Piro","year":"2004","journal-title":"Circulation"},{"key":"10.1111\/jth.15697_bb0175","doi-asserted-by":"crossref","first-page":"2055","DOI":"10.1161\/01.ATV.15.11.2055","article-title":"Thrombin induces the redistribution and acute release of tissue factor pathway inhibitor from specific granules within human endothelial cells in culture","volume":"15","author":"Lupu","year":"1995","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1111\/jth.15697_bb0180","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1073\/pnas.0507195103","article-title":"Polyphosphate modulates blood coagulation and fibrinolysis","volume":"103","author":"Smith","year":"2006","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1111\/jth.15697_bb0185","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1161\/01.ATV.20.3.874","article-title":"Reversible regulation of tissue factor\u2010induced coagulation by glycosyl phosphatidylinositol\u2010anchored tissue factor pathway inhibitor","volume":"20","author":"Ott","year":"2000","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1111\/jth.15697_bb0190","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1182\/blood.V78.2.394.394","article-title":"Purification and properties of heparin\u2010releasable lipoprotein\u2010associated coagulation inhibitor","volume":"78","author":"Novotny","year":"1991","journal-title":"Blood"},{"key":"10.1111\/jth.15697_bb0195","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1038\/338518a0","article-title":"Functional significance of the Kunitz\u2010type inhibitory domains of lipoprotein\u2010associated coagulation inhibitor","volume":"338","author":"Girard","year":"1989","journal-title":"Nature"},{"key":"10.1111\/jth.15697_bb0200","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1182\/blood.V85.1.121.bloodjournal851121","article-title":"Mechanism of antithrombin III inhibition of factor VIIa\/tissue factor activity on cell surfaces. Comparison with tissue factor pathway inhibitor\/factor Xa\u2010induced inhibition of factor VIIa\/tissue factor activity","volume":"85","author":"Rao","year":"1995","journal-title":"Blood"},{"key":"10.1111\/jth.15697_bb0205","doi-asserted-by":"crossref","first-page":"4367","DOI":"10.1074\/jbc.272.7.4367","article-title":"Regulation of tissue factor initiated thrombin generation by the stoichiometric inhibitors tissue factor pathway inhibitor, antithrombin\u2010III, and heparin cofactor\u2010II","volume":"272","author":"van't Veer","year":"1997","journal-title":"J Biol Chem"},{"key":"10.1111\/jth.15697_bb0210","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1046\/j.1538-7836.2003.00254.x","article-title":"Factor Xa is highly protected from antithrombin\u2010fondaparinux and antithrombin\u2010enoxaparin when incorporated into the prothrombinase complex","volume":"1","author":"Brufatto","year":"2003","journal-title":"J Thromb Haemost"},{"key":"10.1111\/jth.15697_bb0215","doi-asserted-by":"crossref","first-page":"2818","DOI":"10.1182\/blood.V91.8.2818.2818_2818_2829","article-title":"Platelet\u2010derived factor Va\/Va Leiden cofactor activities are sustained on the surface of activated platelets despite the presence of activated protein C","volume":"91","author":"Camire","year":"1998","journal-title":"Blood"},{"key":"10.1111\/jth.15697_bb0220","doi-asserted-by":"crossref","first-page":"6648","DOI":"10.1074\/jbc.M708036200","article-title":"Effects of prothrombin on the individual activated protein C\u2010mediated cleavages of coagulation factor Va","volume":"283","author":"Tran","year":"2008","journal-title":"J Biol Chem"},{"issue":"Suppl 2","key":"10.1111\/jth.15697_bb0225","doi-asserted-by":"crossref","first-page":"S28","DOI":"10.1016\/S0049-3848(16)30359-0","article-title":"Targeting TFPI for hemophilia treatment","volume":"141","author":"Peterson","year":"2016","journal-title":"Thromb Res"},{"key":"10.1111\/jth.15697_bb0230","doi-asserted-by":"crossref","first-page":"5260","DOI":"10.1073\/pnas.74.12.5260","article-title":"Activation of factor IX by the reaction product of tissue factor and factor VII: additional pathway for initiating blood coagulation","volume":"74","author":"Osterud","year":"1977","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1111\/jth.15697_bb0235","doi-asserted-by":"crossref","first-page":"4378","DOI":"10.1074\/jbc.273.8.4378","article-title":"Regulation of extrinsic pathway factor Xa formation by tissue factor pathway inhibitor","volume":"273","author":"Baugh","year":"1998","journal-title":"J Biol Chem"},{"key":"10.1111\/jth.15697_bb0240","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.1182\/blood-2017-02-767079","article-title":"Selective factor VIII activation by the tissue factor\u2010factor VIIa\u2010factor Xa complex","volume":"130","author":"Kamikubo","year":"2017","journal-title":"Blood"},{"key":"10.1111\/jth.15697_bb0245","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1182\/blood-2009-10-246686","article-title":"The Kunitz\u20103 domain of TFPI\u2010alpha is required for protein S\u2010dependent enhancement of factor Xa inhibition","volume":"116","author":"Ndonwi","year":"2010","journal-title":"Blood"},{"key":"10.1111\/jth.15697_bb0250","doi-asserted-by":"crossref","first-page":"3106","DOI":"10.1073\/pnas.0504240103","article-title":"Protein S stimulates inhibition of the tissue factor pathway by tissue factor pathway inhibitor","volume":"103","author":"Hackeng","year":"2006","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1111\/jth.15697_bb0255","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.thromres.2014.03.043","article-title":"Inhibitory effects of LDL\u2010associated tissue factor pathway inhibitor","volume":"134","author":"Augustsson","year":"2014","journal-title":"Thromb Res"},{"key":"10.1111\/jth.15697_bb0260","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1161\/CIRCULATIONAHA.113.003191","article-title":"Factor Xa activation of factor V Is of paramount importance in initiating the coagulation system","volume":"128","author":"Schuijt","year":"2013","journal-title":"Circulation"},{"key":"10.1111\/jth.15697_bb0265","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1111\/jth.15547","article-title":"The preAR2 region (1458\u20131492) in factor V\u2010Short is crucial for the synergistic TFPI\u03b1\u2010cofactor activity with protein S and the assembly of a trimolecular factor Xa\u2010inhibitory complex comprising FV\u2010Short, protein S, and TFPI\u03b1","volume":"20","author":"Dahlb\u00e4ck","year":"2022","journal-title":"J Thromb Haemost"},{"key":"10.1111\/jth.15697_bb0270","doi-asserted-by":"crossref","first-page":"2692","DOI":"10.1182\/bloodadvances.2017011098","article-title":"TFPIalpha interacts with FVa and FXa to inhibit prothrombinase during the initiation of coagulation","volume":"1","author":"Wood","year":"2017","journal-title":"Blood Adv"},{"key":"10.1111\/jth.15697_bb0275","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1182\/bloodadvances.2016002295","article-title":"Reduced prothrombinase inhibition by tissue factor pathway inhibitor contributes to the factor V Leiden hypercoagulable state","volume":"1","author":"Wood","year":"2017","journal-title":"Blood Adv"},{"key":"10.1111\/jth.15697_bb0280","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1055\/s-0039-1700516","article-title":"Development of a plasma\u2010based assay to measure the susceptibility of factor V to inhibition by the C\u2010terminus of TFPI\u03b1","volume":"120","author":"van Doorn","year":"2020","journal-title":"Thromb Haemost"},{"key":"10.1111\/jth.15697_bb0285","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.1016\/S0021-9258(17)34206-0","article-title":"Thrombin\u2010catalyzed activation of single chain bovine factor V","volume":"254","author":"Nesheim","year":"1979","journal-title":"J Biol Chem"},{"key":"10.1111\/jth.15697_bb0290","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1111\/jth.13559","article-title":"The C\u2010terminus of tissue factor pathway inhibitor\u2010alpha inhibits factor V activation by protecting the Arg(1545) cleavage site","volume":"15","author":"van Doorn","year":"2017","journal-title":"J Thromb Haemost"},{"key":"10.1111\/jth.15697_bb0295","doi-asserted-by":"crossref","first-page":"3777","DOI":"10.1172\/JCI69091","article-title":"Coagulation factor V(A2440G) causes east Texas bleeding disorder via TFPIalpha","volume":"123","author":"Vincent","year":"2013","journal-title":"J Clin Invest"},{"issue":"3","key":"10.1111\/jth.15697_bb0300","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1111\/jth.15612","article-title":"Factor V east Texas variant causes bleeding in a three\u2010generation family","volume":"20","author":"Peterson","year":"2022","journal-title":"J Thromb Haemost"},{"key":"10.1111\/jth.15697_bb0305","doi-asserted-by":"crossref","first-page":"1822","DOI":"10.1182\/blood-2014-08-592733","article-title":"A novel mutation in the F5 gene (factor V Amsterdam) associated with bleeding independent of factor V procoagulant function","volume":"125","author":"Cunha","year":"2015","journal-title":"Blood"},{"key":"10.1111\/jth.15697_bb0310","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.1111\/jth.15314","article-title":"F5\u2010Atlanta: A novel mutation in F5 associated with enhanced East Texas splicing and FV\u2010short production","volume":"19","author":"Zimowski","year":"2021","journal-title":"J Thromb Haemost"},{"key":"10.1111\/jth.15697_bb0315","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0029964","article-title":"Simukunin from the salivary glands of the black fly Simulium vittatum inhibits enzymes that regulate clotting and inflammatory responses","volume":"7","author":"Tsujimoto","year":"2012","journal-title":"PLoS One"},{"key":"10.1111\/jth.15697_bb0320","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1055\/s-0037-1615947","article-title":"A cell\u2010based model of hemostasis","volume":"85","author":"Hoffman","year":"2001","journal-title":"Thromb Haemost"},{"key":"10.1111\/jth.15697_bb0325","doi-asserted-by":"crossref","first-page":"2161","DOI":"10.1182\/blood-2017-09-807040","article-title":"Paraoxonase\u20102 regulates coagulation activation through endothelial tissue factor","volume":"131","author":"Ebert","year":"2018","journal-title":"Blood"},{"key":"10.1111\/jth.15697_bb0330","doi-asserted-by":"crossref","first-page":"2348","DOI":"10.1046\/j.1538-7836.2003.00428.x","article-title":"Binding studies of the enzyme (factor IXa) with the cofactor (factor VIIIa) in the assembly of factor\u2010X activating complex on the activated platelet surface","volume":"1","author":"Ahmad","year":"2003","journal-title":"J Thromb Haemost"},{"key":"10.1111\/jth.15697_bb0335","doi-asserted-by":"crossref","first-page":"17132","DOI":"10.1016\/S0021-9258(17)44879-4","article-title":"Functional characterization of human platelet\u2010released factor V and its activation by factor Xa and thrombin","volume":"265","author":"Monkovic","year":"1990","journal-title":"J Biol Chem"},{"key":"10.1111\/jth.15697_bb0340","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1161\/ATVBAHA.113.302655","article-title":"Protein S is a cofactor for platelet and endothelial tissue factor pathway inhibitor\u2010alpha but not for cell surface\u2010associated tissue factor pathway inhibitor","volume":"34","author":"Wood","year":"2014","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1111\/jth.15697_bb0345","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1111\/jth.12201","article-title":"Aptamer BAX 499 mediates inhibition of tissue factor pathway inhibitor via interaction with multiple domains of the protein","volume":"11","author":"Waters","year":"2013","journal-title":"J Thromb Haemost"},{"key":"10.1111\/jth.15697_bb0350","first-page":"1","article-title":"Long\u2010term safety and efficacy of the anti\u2010TFPI monoclonal antibody marstacimab in patients with severe haemophilia A or B: results from a phase 2 long\u2010term treatment study [abstract]","volume":"5","author":"Mahlangu","year":"2021","journal-title":"Res Pract Thromb Haemost"},{"key":"10.1111\/jth.15697_bb0355","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1182\/blood-2020-139563","article-title":"Risk mitigation strategy for concizumab clinical trials after pause due to non\u2010fatal thrombotic events","volume":"136","author":"Seremetis","year":"2020","journal-title":"Blood"},{"key":"10.1111\/jth.15697_bb0360","doi-asserted-by":"crossref","first-page":"3927","DOI":"10.1073\/pnas.1119858109","article-title":"Absence of hematopoietic tissue factor pathway inhibitor mitigates bleeding in mice with hemophilia","volume":"109","author":"Maroney","year":"2012","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1111\/jth.15697_bb0365","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1182\/blood-2017-02-768218","article-title":"Identification of the integrin\u2010binding site on coagulation factor VIIa required for proangiogenic PAR2 signaling","volume":"131","author":"Rothmeier","year":"2018","journal-title":"Blood"},{"key":"10.1111\/jth.15697_bb0370","doi-asserted-by":"crossref","first-page":"11189","DOI":"10.1073\/pnas.96.20.11189","article-title":"Protease\u2010activated receptor 1 is the primary mediator of thrombin\u2010stimulated platelet procoagulant activity","volume":"96","author":"Andersen","year":"1999","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1111\/jth.15697_bb0375","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1182\/blood-2007-07-101048","article-title":"Inhibition of tissue factor signaling suppresses tumor growth","volume":"111","author":"Versteeg","year":"2008","journal-title":"Blood"},{"key":"10.1111\/jth.15697_bb0380","doi-asserted-by":"crossref","first-page":"6580","DOI":"10.1074\/jbc.275.9.6580","article-title":"Binding of factor VIIa to tissue factor on keratinocytes induces gene expression","volume":"275","author":"Camerer","year":"2000","journal-title":"J Biol Chem"},{"key":"10.1111\/jth.15697_bb0385","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1172\/JCI7750","article-title":"Tumor cell adhesion and migration supported by interaction of a receptor\u2010protease complex with its inhibitor","volume":"104","author":"Fischer","year":"1999","journal-title":"J Clin Invest"},{"key":"10.1111\/jth.15697_bb0390","doi-asserted-by":"crossref","first-page":"3452","DOI":"10.1182\/blood.V96.10.3452","article-title":"Binding of factor VIIa to tissue factor on human fibroblasts leads to activation of phospholipase C and enhanced PDGF\u2010BB\u2010stimulated chemotaxis","volume":"96","author":"Siegbahn","year":"2000","journal-title":"Blood"},{"key":"10.1111\/jth.15697_bb0395","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1161\/ATVBAHA.107.142539","article-title":"Role of protease activated receptor 1 and 2 signaling in hypoxia\u2010induced angiogenesis","volume":"27","author":"Uusitalo\u2010Jarvinen","year":"2007","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1111\/jth.15697_bb0400","doi-asserted-by":"crossref","first-page":"32379","DOI":"10.1074\/jbc.M114.599332","article-title":"The Eph tyrosine kinase receptors EphB2 and EphA2 are novel proteolytic substrates of tissue factor\/coagulation factor VIIa","volume":"289","author":"Eriksson","year":"2014","journal-title":"J Biol Chem"},{"key":"10.1111\/jth.15697_bb0405","doi-asserted-by":"crossref","first-page":"5756","DOI":"10.1074\/jbc.M110.201228","article-title":"The endothelial protein C receptor supports tissue factor ternary coagulation initiation complex signaling through protease\u2010activated receptors","volume":"286","author":"Disse","year":"2011","journal-title":"J Biol Chem"},{"key":"10.1111\/jth.15697_bb0410","doi-asserted-by":"crossref","DOI":"10.1126\/science.abc0956","article-title":"Lipid presentation by the protein C receptor links coagulation with autoimmunity","volume":"371","author":"Muller\u2010Calleja","year":"2021","journal-title":"Science"},{"key":"10.1111\/jth.15697_bb0415","doi-asserted-by":"crossref","first-page":"2845","DOI":"10.1182\/blood-2014-11-610717","article-title":"EPCR\u2010dependent PAR2 activation by the blood coagulation initiation complex regulates LPS\u2010triggered interferon responses in mice","volume":"125","author":"Liang","year":"2015","journal-title":"Blood"},{"key":"10.1111\/jth.15697_bb0420","doi-asserted-by":"crossref","first-page":"2415","DOI":"10.1182\/blood-2015-05-644401","article-title":"Coagulation factor V mediates inhibition of tissue factor signaling by activated protein C in mice","volume":"126","author":"Liang","year":"2015","journal-title":"Blood"},{"key":"10.1111\/jth.15697_bb0425","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.aaw8405","article-title":"Myeloid cell\u2010synthesized coagulation factor X dampens antitumor immunity","volume":"4","author":"Graf","year":"2019","journal-title":"Sci Immunol"},{"key":"10.1111\/jth.15697_bb0430","doi-asserted-by":"crossref","first-page":"2030","DOI":"10.1172\/JCI111922","article-title":"Human alveolar macrophages synthesize factor VII in vitro. Possible role in interstitial lung disease","volume":"75","author":"Chapman","year":"1985","journal-title":"J Clin Invest"},{"key":"10.1111\/jth.15697_bb0435","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1038\/ni.2419","article-title":"Gene\u2010expression profiles and transcriptional regulatory pathways that underlie the identity and diversity of mouse tissue macrophages","volume":"13","author":"Gautier","year":"2012","journal-title":"Nat Immunol"},{"key":"10.1111\/jth.15697_bb0440","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1182\/blood-2017-12-768986","article-title":"Extravascular coagulation in hematopoietic stem and progenitor cell regulation","volume":"132","author":"Nguyen","year":"2018","journal-title":"Blood"},{"key":"10.1111\/jth.15697_bb0445","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1038\/nm.3960","article-title":"PAR1 signaling regulates the retention and recruitment of EPCR\u2010expressing bone marrow hematopoietic stem cells","volume":"21","author":"Gur\u2010Cohen","year":"2015","journal-title":"Nat Med"},{"key":"10.1111\/jth.15697_bb0450","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1084\/jem.20182024","article-title":"Expression of factor V by resident macrophages boosts host defense in the peritoneal cavity","volume":"216","author":"Zhang","year":"2019","journal-title":"J Exp Med"},{"key":"10.1111\/jth.15697_bb0455","first-page":"310","article-title":"Inhibitory properties of separate recombinant Kunitz\u2010type\u2010protease\u2010inhibitor domains from tissue\u2010factor\u2010pathway","volume":"235","author":"Petersen","year":"1996","journal-title":"Inhibitor"},{"key":"10.1111\/jth.15697_bb0460","doi-asserted-by":"crossref","first-page":"1826","DOI":"10.1111\/jth.12713","article-title":"Inhibition of tissue factor:factor VIIa\u2010catalyzed factor IX and factor X activation by TFPI and TFPI constructs","volume":"12","author":"Peraramelli","year":"2014","journal-title":"J Thromb Haemost"},{"key":"10.1111\/jth.15697_bb0465","doi-asserted-by":"crossref","first-page":"2850","DOI":"10.1172\/JCI116529","article-title":"Tissue factor pathway inhibitor (TFPI) reduces mortality from E. coli septic shock","volume":"91","author":"Creasey","year":"1993","journal-title":"J Clin Invest"},{"key":"10.1111\/jth.15697_bb0470","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1055\/s-0038-1648489","article-title":"Effect of leukocyte proteinases on tissue factor pathway inhibitor","volume":"67","author":"Petersen","year":"1992","journal-title":"Thromb Haemost"},{"key":"10.1111\/jth.15697_bb0475","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1161\/ATVBAHA.117.309315","article-title":"Tissue factor prothrombotic activity is regulated by integrin\u2010arf6 trafficking","volume":"37","author":"Rothmeier","year":"2017","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1111\/jth.15697_bb0480","doi-asserted-by":"crossref","first-page":"6664","DOI":"10.1073\/pnas.91.14.6664","article-title":"The low density lipoprotein receptor\u2010related protein mediates the cellular degradation of tissue factor pathway inhibitor","volume":"91","author":"Warshawsky","year":"1994","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1111\/jth.15697_bb0485","doi-asserted-by":"crossref","first-page":"12241","DOI":"10.1074\/jbc.M010395200","article-title":"Tissue factor pathway inhibitor inhibits endothelial cell proliferation via association with the very low density lipoprotein receptor","volume":"276","author":"Hembrough","year":"2001","journal-title":"J Biol Chem"},{"key":"10.1111\/jth.15697_bb0490","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1042\/BJ20111994","article-title":"Caveolae optimize tissue factor\u2010factor VIIa inhibitory activity of cell surface associated tissue factor pathway inhibitor","volume":"443","author":"Maroney","year":"2012","journal-title":"Biochem J"},{"key":"10.1111\/jth.15697_bb0495","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1002\/mc.22329","article-title":"Endothelial cell\u2010anchored tissue factor pathway inhibitor regulates tumor metastasis to the lung in mice","volume":"55","author":"Wang","year":"2016","journal-title":"Mol Carcinog"},{"key":"10.1111\/jth.15697_bb0500","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1182\/blood.V90.3.944","article-title":"Tissue factor pathway inhibitor gene disruption produces intrauterine lethality in mice","volume":"90","author":"Huang","year":"1997","journal-title":"Blood"},{"key":"10.1111\/jth.15697_bb0505","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1182\/blood.2020006054","article-title":"Tissue factor pathway inhibitor is required for cerebrovascular development in mice","volume":"137","author":"Maroney","year":"2021","journal-title":"Blood"},{"key":"10.1111\/jth.15697_bb0510","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1111\/jth.15299","article-title":"Intrauterine lethality in Tfpi gene disrupted mice is differentially suppressed during mid\u2010 and late\u2010gestation by platelet TFPIalpha overexpression","volume":"19","author":"Siebert","year":"2021","journal-title":"J Thromb Haemost"},{"key":"10.1111\/jth.15697_bb0515","doi-asserted-by":"crossref","first-page":"2139","DOI":"10.1161\/01.CIR.0000017361.39256.82","article-title":"Lethal perinatal thrombosis in mice resulting from the interaction of tissue factor pathway inhibitor deficiency and factor V Leiden","volume":"105","author":"Eitzman","year":"2002","journal-title":"Circulation"},{"key":"10.1111\/jth.15697_bb0520","first-page":"2997","article-title":"Tissue factor\/factor VIIa inhibitors block angiogenesis and tumor growth through a nonhemostatic mechanism","volume":"63","author":"Hembrough","year":"2003","journal-title":"Cancer Res"},{"key":"10.1111\/jth.15697_bb0525","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1161\/ATVBAHA.111.243733","article-title":"Tissue factor pathway inhibitor blocks angiogenesis via its carboxyl terminus","volume":"32","author":"Holroyd","year":"2012","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1111\/jth.15697_bb0530","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1161\/hc0302.103591","article-title":"Proteolysis of tissue factor pathway inhibitor\u20101 by thrombolysis in acute myocardial infarction","volume":"105","author":"Ott","year":"2002","journal-title":"Circulation"},{"key":"10.1111\/jth.15697_bb0535","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1038\/nm.2184","article-title":"Reciprocal coupling of coagulation and innate immunity via neutrophil serine proteases","volume":"16","author":"Massberg","year":"2010","journal-title":"Nat Med"},{"key":"10.1111\/jth.15697_bb0540","series-title":"Bacterial Endotoxins: Basic Science to Anti\u2010Sepsis Strategies","first-page":"175","article-title":"Studies on the inflammatory\u2010coagulant axis in the baboon response to E. coli: regulatory roles of proteins C, S, C4bBP and of inhibitors of tissue factor","author":"Taylor","year":"1994"},{"key":"10.1111\/jth.15697_bb0545","doi-asserted-by":"crossref","first-page":"5127","DOI":"10.1038\/s41598-021-84695-8","article-title":"Tissue factor pathway inhibitor upregulates CXCR7 expression and enhances CXCL12\u2010mediated migration in chronic lymphocytic leukemia","volume":"11","author":"Cui","year":"2021","journal-title":"Sci Rep"},{"key":"10.1111\/jth.15697_bb0550","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1186\/1471-2407-11-357","article-title":"Downregulation of TFPI in breast cancer cells induces tyrosine phosphorylation signaling and increases metastatic growth by stimulating cell motility","volume":"11","author":"Stavik","year":"2011","journal-title":"BMC Cancer"},{"key":"10.1111\/jth.15697_bb0555","doi-asserted-by":"crossref","first-page":"3044","DOI":"10.1161\/hc2501.092492","article-title":"Deficiency of tissue factor pathway inhibitor promotes atherosclerosis and thrombosis in mice","volume":"103","author":"Westrick","year":"2001","journal-title":"Circulation"},{"key":"10.1111\/jth.15697_bb0560","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1161\/CIRCRESAHA.109.195016","article-title":"Vascular\u2010directed tissue factor pathway inhibitor overexpression regulates plasma cholesterol and reduces atherosclerotic plaque development","volume":"105","author":"Pan","year":"2009","journal-title":"Circ Res"},{"key":"10.1111\/jth.15697_bb0565","doi-asserted-by":"crossref","first-page":"2191","DOI":"10.1111\/j.1538-7836.2006.02100.x","article-title":"Postinjury vascular intimal hyperplasia in mice is completely inhibited by CD34+ bone marrow\u2010derived progenitor cells expressing membrane\u2010tethered anticoagulant fusion proteins","volume":"4","author":"Chen","year":"2006","journal-title":"J Thromb Haemost"},{"key":"10.1111\/jth.15697_bb0570","doi-asserted-by":"crossref","first-page":"S200","DOI":"10.1111\/jth.12897","article-title":"New insights into the biology of tissue factor pathway inhibitor","volume":"13","author":"Maroney","year":"2015","journal-title":"J Thromb Haemost"}],"container-title":["Journal of Thrombosis and Haemostasis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/jth.15697","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1111\/jth.15697","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538783622001921?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538783622001921?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/jth.15697","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T03:34:03Z","timestamp":1761536043000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1538783622001921"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6]]},"references-count":113,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2022,6]]}},"alternative-id":["S1538783622001921"],"URL":"https:\/\/doi.org\/10.1111\/jth.15697","relation":{},"ISSN":["1538-7836"],"issn-type":[{"value":"1538-7836","type":"print"}],"subject":[],"published":{"date-parts":[[2022,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Regulation of coagulation by tissue factor pathway inhibitor: Implications for hemophilia therapy","name":"articletitle","label":"Article Title"},{"value":"Journal of Thrombosis and Haemostasis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1111\/jth.15697","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2022 The Authors. Journal of Thrombosis and Haemostasis published by ELSEVIER INC. on behalf of International Society on Thrombosis and Haemostasis","name":"copyright","label":"Copyright"}]}}